Atomoxetine manufacturer?

The primary manufacturer of Atomoxetine is Eli Lilly and Company [1]. Atomoxetine is marketed under the brand name Strattera [2].

Who else sells generic Atomoxetine?

Following patent expirations, other pharmaceutical companies have begun manufacturing and distributing generic versions of atomoxetine. These include Teva Pharmaceuticals, Mylan, and Aurobindo Pharma, among others [1].

When did Atomoxetine's patent expire?

The patent for atomoxetine (Strattera) expired in the United States in 2017 [3]. This allowed for the introduction of generic versions of the drug. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals [4].

What is Atomoxetine used for?

Atomoxetine is a medication primarily used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents, and adults [5]. It works by increasing the levels of norepinephrine, a neurotransmitter in the brain that plays a role in attention and impulse control [6].